1887

Abstract

Summary

A collection of monoclonal antibodies (MAbs) which react with the haemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) has been used to isolate MAb-resistant mutants of the Beaudette C strain of NDV. The patterns of cross-reactivity of the HN proteins of these mutants against the collection of MAbs determined by Western blotting allowed the MAbs to be sorted into different groups. Protease V8 partial digest fragments of purified wild-type virions and subsequent reaction against the collection of MAbs using Western blotting provided an alternative method of grouping MAbs which broadly agreed with the former method. Chemical cleavage of the HN protein at aspartate-proline bonds followed by Western blotting of the fragments allowed the approximate position of certain MAb binding sites to be determined.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-2-473
1988-02-01
2022-01-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/2/JV0690020473.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-2-473&mimeType=html&fmt=ahah

References

  1. CHAMBERS P., SAMSON A. C R. 1980; A new structural protein for Newcastle disease virus. Journal of General Virology 50:155–166
    [Google Scholar]
  2. CHOPPIN P. W., SCHEID A. 1980; The role of viral glycoproteins in adsorption, penetration and pathogenicity of viruses. Reviews of Infectious Diseases 2:40–61
    [Google Scholar]
  3. COELINGH K. I., WINTER C. C, MURPHY B. R., RICE J. M., KIMBALL P.C., OLMSTED R. A., COLLINS P. L. 1986; Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 viruses: nucleotide sequence analysis of variants selected with monoclonal antibodies. Journal of Virology 60:90–96
    [Google Scholar]
  4. IORIO R. M., BRATT M. A. 1984; Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites. Journal of Immunology 133:2215–2219
    [Google Scholar]
  5. IORIO R. H., BRATT M. A. 1985; Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin. Proceedings of the National Academy of Sciences, U.S.A 82:7106–7110
    [Google Scholar]
  6. IORIO R. M., BORGMAN J. B., GLICKMAN R. L., BRATT M. A. 1986; Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. Journal of General Virology 67:1393–1403
    [Google Scholar]
  7. JORGENSEN E. D., COLLINS P. L., LOMEDICO P. T. 1987; Cloning and nucleotide sequence of Newcastle disease virus haemagglutinin-neuraminidase mRNA: identification of a putative sialic acid binding site. Virology 156:12–24
    [Google Scholar]
  8. LAEMMLI U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
  9. LE LONG, PORTETELLE D., GHYSDAEL J., GONZE M., BURNY A., MEULEMANS G. 1986; Monoclonal antibodies to hemagglutinin-neuraminidase and fusion glycoproteins of Newcastle disease virus: relationship between glycosylation and reactivity. Journal of Virology 57:1198–1202
    [Google Scholar]
  10. MEULEMANS G., GONZE M., CARLIER M. C, PETIT P., BURNY A., LE LONG. 1986; Protective effects of HN and F glycoprotein-specific monoclonal antibodies on experimental Newcastle disease. Avian Pathology 15:761–768
    [Google Scholar]
  11. MILLAR N. S., CHAMBERS P., EMMERSON P. T. 1986; Nucleotide sequence analysis of the haemagglutinin-neuraminidase gene of Newcastle disease virus. Journal of General Virology 67:1917–1927
    [Google Scholar]
  12. NISHIKAWA K., ISOMURA S., SUZUKI S., WATANABE E., HAMAGUCHI M., YOSHIDA T., NAGAI Y. 1983; Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons. Virology 130:318–330
    [Google Scholar]
  13. NISHIKAWA K., MORISHIMA T., TOYODA T., MIYADAI T., YOKOCHI T., YOSHIDA T., NAGAI Y. 1986; Topological and operational delineation of antigenic sites on the HN glycoprotein of Newcastle disease virus and their structural requirements. Journal of Virology 60:987–993
    [Google Scholar]
  14. PISZKIEWICZ D., LANDON M., SMITH E. L. 1970; Anomalous cleavage of aspartyl-proline peptide bonds during amino acid sequence determinations. Biochemical and Biophysical Research Communications 40:1173–1178
    [Google Scholar]
  15. PORTNER A., SCROGGS R. A., NAEVE C. W. 1987; The fusion glycoprotein of Sendai virus: sequence analysis of an epitope involved in fusion and virus neutralization. Virology 157:556–559
    [Google Scholar]
  16. RUSSELL P. H., ALEXANDER D. J. 1983; Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies. Archives of Virology 75:243–252
    [Google Scholar]
  17. RUSSELL P. H., GRIFFITHS P. C, GOSWAMI K. K. A., ALEXANDER D. J., CANNON M. I., RUSSELL W. C. 1983; The characterization of monoclonal antibodies to Newcastle disease virus. Journal of General Virology 64:2069–2072
    [Google Scholar]
  18. SAMSON A. C. R. 1986; Anomalous behaviour of Newcastle disease virus haemagglutinin-neuraminidase protein in Western blotting analysis of monoclonal antibody binding sites. Journal of General Virology 67:1199–1203
    [Google Scholar]
  19. SAMSON A. C. R., RUSSELL P. H., HALLAM S. E. 1985; Isolation and characterization of monoclonal antibody-resistant mutants of Newcastle disease virus. Journal of General Virology 66:357–361
    [Google Scholar]
  20. WILEY D. C, WILSON I. A., SKEHEL J. J. 1981; Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature, London 289:373–378
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-2-473
Loading
/content/journal/jgv/10.1099/0022-1317-69-2-473
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error